News
Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...
This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...
1d
Independent Newspaper Nigeria on MSNLung Infections, Assisted Reproductive Technology, And The Way Forward To PregnancyCystic fibrosis is an illness best known for causing frequent lung infections and chronic breathing problems. However, it affects organs and tissues throughout the body, including the urogenital ...
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the ...
FORMER Dancing With The Stars judge Julian Benson has died after a “courageous battle” with Cystic Fibrosis. The talented ...
The Martina Natoli Lagman Foundation held its 4th annual womanless beauty pageant and comedy show, raising money for cystic fibrosis patients across the nation.
cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in ... New Screening Device ...
1d
MedPage Today on MSNNovel DPP-1 Drug Trims Exacerbation Risk in BronchiectasisThe dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...
Dancing with the Stars icon Julian Benson has died after a 'courageous' lifelong battle with cystic fibrosis. The Australian choreographer, 54, made a name for himself as a judge on the Irish edition ...
2d
News-Medical.Net on MSNOwlstone Medical announces investment of up to $2.3 million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detectio…Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy ® for applications in early disease detection and precision ...
Incorporated announced that positive results from the pivotal phase 3 ASPEN study of brensocatib in patients with non-cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results